AGILENT TECHNOLOGIES, INC. is 35.8x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($37.02 B vs $1.03 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EYPT | A |
|---|---|---|
| Market cap | $1.03 B | $37.02 B |
| US-listed rank | #2607 | #407 |
| Revenue (latest FY) | $31.37M | $6.95B |
| Net income (latest FY) | -$231.96M | $1.30B |
| Net margin | -739.4% | 18.8% |
| P/E (trailing FY) | - | 28.4 |
| SEC filings | 1,308 | 2,339 |
AGILENT TECHNOLOGIES, INC. is 35.8x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($37.02 B vs $1.03 B).
In their latest fiscal years, EyePoint Pharmaceuticals, Inc. reported $31.37M in revenue while AGILENT TECHNOLOGIES, INC. reported $6.95B.
Full pages: EyePoint Pharmaceuticals, Inc. and AGILENT TECHNOLOGIES, INC., or browse the full rankings.